Heart failure & cardiomyopathies

Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis

Eur Heart J Cardiovasc ImagingPublished Retrospective cohort study

Authors' conclusion

In a large cohort of patients with CA, MR, and TR were common. Isolated TR and combined MR/TR were associated with worse prognosis regardless of CA aetiology, LV, and RV function, with TR carrying the highest risk.

Study context

Population
Patients with cardiac amyloidosis (ATTR or AL)ATTR n = 359
Participants
538 patients
Exposure
Isolated mitral regurgitation (MR), isolated tricuspid regurgitation (TR) or combined MR/TR vs no significant MR/TR
  • No significant MR/TRn = 240reference
  • Isolated MRn = 112
  • Isolated TRn = 66
  • Combined MR/TRn = 120
Outcome
All-cause death or worsening HF events
Methodological detailsmulticentre, three Italian referral centres
  • Multicentre
  • Three Italian referral centres

Main finding

As reported in the abstract

Prevalence of MR/TR

Observational data: associations, not effects.

Further findings

OutcomeAdjusted HR (CI)
All-cause death or worsening HF eventsIsolated TRvs No significant MR/TR2.75 (1.78–4.24)
All-cause death or worsening HF eventsCombined MR/TRvs No significant MR/TR2.31 (1.44–3.70)
  • All-cause death or worsening HF events: adjusted for age, sex, cardiac amyloidosis (CA) subtypes, laboratory and echocardiographic markers of CA severity

Original publication

Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. Published 18 March 2024. doi:10.1093/ehjci/jeae060

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.